109 related articles for article (PubMed ID: 22299583)
1. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of amides of tripeptides as potential urokinase inhibitors.
Markowska A; Bruzgo I; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):139-42. PubMed ID: 20030517
[TBL] [Abstract][Full Text] [Related]
3. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
4. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
5. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.
Turpeinen U; Koivunen E; Stenman UH
Biochem J; 1988 Sep; 254(3):911-4. PubMed ID: 2461702
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of N-sulfonylamides of tripeptides as potential urokinase inhibitors.
Markowska A; Bruzgo I; Miltyk W; Midura-Nowaczek K
Protein Pept Lett; 2010 Oct; 17(10):1300-4. PubMed ID: 20594155
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
Teno N; Otsubo T; Gohda K; Wanaka K; Sueda T; Ikeda K; Hijikata-Okunomiya A; Tsuda Y
J Pept Sci; 2012 Oct; 18(10):620-5. PubMed ID: 22961872
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
Gilboa N; Villannueva GB; Fenton JW
Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Activity of
Markowska A; Bruzgo M; Gorodkiewicz E; Surażyński A
Int J Pept Res Ther; 2013; 19(3):191-198. PubMed ID: 23926446
[TBL] [Abstract][Full Text] [Related]
10. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
Fukumizu A; Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
Bhongade BA; Gouripur VV; Gadad AK
Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
[TBL] [Abstract][Full Text] [Related]
12. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
13. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
15. Inhibition activities of natural products on serine proteases.
Jedinák A; Maliar T; Grancai D; Nagy M
Phytother Res; 2006 Mar; 20(3):214-7. PubMed ID: 16521112
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
Wienand A; Ehrhardt C; Metternich R; Tapparelli C
Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
[TBL] [Abstract][Full Text] [Related]
17. Protease-inhibitory activities of leupeptin analogues.
Saino T; Someno T; Ishii S; Aoyagi T; Umezawa H
J Antibiot (Tokyo); 1988 Feb; 41(2):220-5. PubMed ID: 2965694
[TBL] [Abstract][Full Text] [Related]
18. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
Pućkowska A; Midura-Nowaczek K; Bruzgo I
Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.
Xue F; Seto CT
J Med Chem; 2005 Nov; 48(22):6908-17. PubMed ID: 16250649
[TBL] [Abstract][Full Text] [Related]
20. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.
Osterwalder T; Cinelli P; Baici A; Pennella A; Krueger SR; Schrimpf SP; Meins M; Sonderegger P
J Biol Chem; 1998 Jan; 273(4):2312-21. PubMed ID: 9442076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
